Lysophosphatidic acid receptor type-1 mediates brain activation in micro-positron emission tomography analysis in a fibromyalgia-like mouse model.
Hiroyuki NeyamaMichiko NishiyoriYilong CuiYasuyoshi WatanabeHiroshi UedaPublished in: The European journal of neuroscience (2022)
The intermittent cold stress-induced generalized pain response mimics the pathophysiological and pharmacotherapeutic features reported for fibromyalgia patients, including the presence of chronic generalized pain and female dominance. In addition, the intermittent cold stress-induced generalized pain is abolished in lysophosphatidic acid receptor type-1 knockout mice, as reported in many cases of neuropathic pain models. This study aimed to identify the brain loci involved in the intermittent cold stress generalized pain response and test their dependence on the lysophosphatidic acid receptor type-1. Positron emission tomography analyses using 2-deoxy-2-[ 18 F]fluoro-d-glucose in the presence of a pain stimulus showed that intermittent cold stress causes a significant increase in uptake in the ipsilateral regions, including the salience networking-related anterior cingulate cortex and insular cortex and the cognition-related hippocampus. A significant decrease was observed in the default mode network-related posterior cingulate cortex. Almost these intermittent cold stress-induced changes were abolished in lysophosphatidic acid receptor type-1 knockout mice. There results suggest that the intermittent cold stress-induced generalized pain response is mediated by the lysophosphatidic acid receptor type-1 in specific brain loci related to salience networking and cognition, which may lead to further developments in the treatment of fibromyalgia.
Keyphrases
- stress induced
- neuropathic pain
- positron emission tomography
- functional connectivity
- resting state
- chronic pain
- computed tomography
- pain management
- spinal cord
- spinal cord injury
- high intensity
- white matter
- mouse model
- pet imaging
- type diabetes
- pet ct
- end stage renal disease
- gene expression
- adipose tissue
- brain injury
- cognitive impairment
- drug induced
- blood pressure
- cerebral ischemia
- mild cognitive impairment
- multiple sclerosis
- skeletal muscle
- combination therapy
- patient reported
- prognostic factors
- weight loss